
Lundbeck acquiring Prexton in €905m deal
Under the deal, Merck-Serono spin-out company Prexton will receive an upfront payment of €100m and is eligible to bag up to €805 million in...

Inhaled IL-4 halts neuron destruction in MS models
The researchers headed by Frauke Zipp from University Hospital Mainz, Germany, say their findings could pave the way toward unconventional and...

Sanofi acquiring Ablynx
Sanofi offered to acquire all outstanding ordinary shares, including Ablynx’ American Depositary Shares (ADSs), warrants and convertible bonds at a...

Bioeconomy: Germany to lose pole position
In a policy paper, the Council members call for investments of at least €3bn over the next six years, more public engagement and political backing...

MYR Pharma completes chronic hepatitis delta POC trial
In February, the company had announced that Myrcludex B + interferon treatment was well tolerated by 60 patients with chronic hepatitis D during the...

PharmaMar in licence deal with Seattle Genetics
Under the deal, Seattle Genetics will get the exclusive worldwide rights to some proprietary sea-derived toxic payloads of PharmaMar for the...

European biotech stocks: 2017 with strong results
Following the more cautious year 2016, the European biotech sector witnessed a significant volume increase in IPOs and follow-on financings in 2017....